SL Science Holding Limited Ordinary Shares (SLBT) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−431.1x

Market Cap

$1.61B

MomentumView details →

1D Return

−8.57%

YTD Return

—

RSI (14)

49.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−431.1x

Market Cap

$1.61B

RSI (14)

49.2

MomentumView details →

1D Return

−8.57%

YTD Return

—

ProfitabilityView details →

Gross Margin

35.27%

Net Margin

−173.85%

EBITDA Margin

−170.39%

ROE (TTM)

−167.25%

ROA (TTM)

−135.59%

Asset Turnover

0.51x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+58.11%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

3.05x

Quick Ratio

3.05x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for SLBT.

Similar companies

Forte Biosciences, Inc.FBRX LB Pharmaceuticals Inc Common StockLBRX Guangzhou Innogen Pharmaceutl Grp Co Ltd02591.HK NewAmsterdam Pharma Company N.V.NAMSW ASCENTAGE PHARMA GROUP INTERNATIONALAAPG SinoMab BioScience Limited03681.HK Find similar companies →

Latest newsMore news →

No recent news for SLBT.